-- As global demand for anti-aging and cellular health products accelerates, Aeternum, a science-first longevity startup, is gaining international attention. Since launching in 2019, the company has achieved over 100% year-on-year revenue growth, expanded to more than 40 countries, and positioned itself as a leading innovator in longevity supplements and next-generation diagnostics.
Founded by architect-turned-biotech entrepreneur Oliver Foster, Aeternum sets itself apart with a strict focus on peer-reviewed, clinically validated ingredients—including NMN, Fisetin, GlyNAC, and Urolithin A. With in-house R&D capabilities and a vertically integrated model, the company combines rigorous science with direct-to-consumer accessibility.
“We’re not in the business of selling hype. Everything we formulate is built on hard science and validated research,” said Foster. “Aeternum is about empowering individuals to take control of their biological future with transparency, trust, and tools that actually work.”
From Startup to Global Brand in Just Two Years
Through its e-commerce platform, Aeternum now ships premium longevity products to customers across North America, Europe, and the Asia-Pacific region. The brand’s rapid international traction is credited to its data-driven approach, transparent formulation strategy, and growing global community of bio-optimization enthusiasts.
Pioneering Biological Age Diagnostics
In addition to its supplements, Aeternum is piloting a biological age testing kit using epigenetic markers to provide users with a science-backed assessment of their cellular age. Early data reveals a 30% increase in supplement adherence among users who received their biological age report—a sign that personalization and education are key drivers in the longevity space.
“This isn’t about vanity,” said Foster. “It’s about evidence-based tools that give people clarity, control, and confidence in their long-term health strategy.”
2025 Roadmap: Personalized Nutrition and Strategic Retail
Aeternum’s growth plans for 2025 include:
- AI-Powered Nutrition Engine – Custom supplement stacks based on biomarkers and lifestyle data
- Retail Expansion – Partnerships with pharmacies and wellness retailers in key international markets
- Advanced Diagnostics – New offerings in gut microbiome profiling and proteomic analysis set for Q4 launch
With the anti-aging sector projected to hit $88 billion by 2027, Aeternum is on track to become a cornerstone of the next generation of health optimization companies.
“We’re building the Tesla of longevity,” Foster noted. “Precision, science, and real-world results—not marketing fluff—will define the leaders in this space.”
About Aeternum
Founded in 2019, Aeternum is a data-driven longevity company developing science-backed supplements and diagnostics to help consumers extend healthspan and optimize cellular performance. With a vertically integrated infrastructure, global reach, and a personalized health philosophy, Aeternum is redefining the future of aging—one biological marker at a time.
Website: www.aeternum.site
Contact Info:
Name: Anna Stone
Email: Send Email
Organization: Aeternum
Website: https://www.aeternum.site
Release ID: 89165433
Google
RSS